Company | Name | Exchange | Sector | Industry | 1 Year | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renewal Fuels | OTC Markets | Industrials | Professional & Commercial Services | 17,969,900% | $290.94M | -589.5x | $0.18 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| NDT Pharmaceuticals Inc | OTC Markets | Healthcare | Pharmaceuticals | 741.5% | $98.08M | $0.51 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
| Tenet Fintech | OTC Markets | Technology | Financial Technology (Fintech) & Infrastructure | 413% | $71.57M | -0.2 | $0.17 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Nanobiotix | NASDAQ | Healthcare | Biotechnology & Medical Research | 331.4% | $2.25B | -74.9x | -1.23 | $43.55 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.9% Downside | Upgrade to Pro+ | |
| Aclaris Therapeutics Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | 256.1% | $943.54M | -11.1x | -0.23 | $6.41 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Nuvation Bio | NYSE | Healthcare | Biotechnology & Medical Research | 139% | $2.43B | -15.8x | -0.55 | $6.93 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Candel Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 120.7% | $1B | -8.9x | 0.06 | $13.13 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Valterra Platinum DRC | OTC Markets | Basic Materials | Metals & Mining | 102.9% | $24.45B | 10.8x | 0 | $15.51 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Unifi | NYSE | Consumer Cyclicals | Textiles & Apparel | 82.1% | $149.26M | -6.1x | 0.31 | $8.03 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.4% Upside | Upgrade to Pro+ | |
| Agenus | NASDAQ | Healthcare | Biotechnology & Medical Research | 79% | $364.22M | 3.2x | 0.03 | $8.09 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Precigen | NASDAQ | Healthcare | Pharmaceuticals | 72.2% | $2.58B | -7.3x | 0.06 | $7.20 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Pan American Silver NQ | NYSE | Basic Materials | Metals & Mining | 64.2% | $22.14B | 15.8x | 0.12 | $53.07 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.5% Upside | Upgrade to Pro+ | |
| Acrivon Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 62.5% | $94.71M | -0.08 | $2.21 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Duos Tech | NASDAQ | Technology | Software & IT Services | 59.3% | $324.80M | 7x | 0.03 | $10.32 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Neutron Holdings | NASDAQ | Consumer Cyclicals | Automobiles & Auto Parts | 57.9% | $2.67B | 4.6x | $41.06 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.6% Downside | Upgrade to Pro+ | ||
| Bloomin Brands | NASDAQ | Consumer Cyclicals | Hotels & Entertainment Services | 57.9% | $995.77M | 34.6x | 0.06 | $11.63 | 11% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
| Expensify | NASDAQ | Technology | Software & IT Services | 44.3% | $240.73M | -13.3x | -5.32 | $2.64 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
| Goldquest Mining | OTC Markets | Basic Materials | Metals & Mining | 42.9% | $272.51M | -18.3x | 0.07 | $0.71 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Rani Therapeutics Holdings | NASDAQ | Healthcare | Biotechnology & Medical Research | 40.9% | $122.67M | -4x | -0.04 | $0.88 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Autolus Therapeutics | NASDAQ | Healthcare | Pharmaceuticals | 37.7% | $641.45M | -2.3x | 0.11 | $2.41 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Blusky AI | OTC Markets | Technology | Software & IT Services | 29.5% | $277.16M | -21.5x | -2.23 | $11.01 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.6% Upside | Upgrade to Pro+ | |
| Viridian Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 26.3% | $2.75B | -7x | -2.78 | $24.29 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.2% Upside | Upgrade to Pro+ | |
| Dillards | NYSE | Consumer Cyclicals | Diversified Retail | 21.7% | $9.71B | 14.1x | 0.7 | $621.63 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.5% Downside | Upgrade to Pro+ | |
| Future Vision II Acquisition Unt | NASDAQ | Financials | Investment Holding Companies | 16.5% | $98.07M | 0.2 | $12.23 | -10.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| NTT Inc | OTC Markets | Technology | Telecommunications Services | 12.2% | $85.07B | 12.9x | 1.51 | $1.04 | 10.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Editas Medicine | NASDAQ | Healthcare | Biotechnology & Medical Research | 11.1% | $477.63M | -4.2x | -0.09 | $3.11 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Crispr Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 9.5% | $5.75B | -12.5x | -1.01 | $59.50 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.5% Upside | Upgrade to Pro+ | |
| Sana Biotechnology | NASDAQ | Healthcare | Biotechnology & Medical Research | 9.2% | $1.17B | -5.1x | -0.2 | $3.91 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Burning Rock | NASDAQ | Healthcare | Healthcare Providers & Services | 4.7% | $103.14M | -11.6x | -0.15 | $9.78 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Schrodinger | NASDAQ | Technology | Software & IT Services | -3% | $1.47B | -27x | -0.39 | $19.71 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
| Boss Energy | OTC Markets | Energy | Uranium | -3.4% | $452.54M | -19x | 0.45 | $1.14 | 9.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Ocular Therapeutix Inc | NASDAQ | Healthcare | Pharmaceuticals | -9.9% | $2.43B | -7.8x | 0.77 | $11.08 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Cartesian Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | -10.6% | $303.76M | -1.8x | 0.01 | $10.04 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Neonc Technologies Holdings | NASDAQ | Healthcare | Biotechnology & Medical Research | -19.7% | $116.21M | -0.32 | $4.68 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| CyberAgent ADR | OTC Markets | Consumer Cyclicals | Media & Publishing | -22.7% | $4.16B | 16x | 0.19 | $4.64 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Axe Compute | NASDAQ | Healthcare | Biotechnology & Medical Research | -26.8% | $118.35M | -0.9x | 0 | $10.21 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Coinshares | NASDAQ | Financials | Investment Banking & Investment Services | -32.5% | $766.30M | -0.24 | $5.82 | 7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | ||
| Real Brokerage | NASDAQ | Real Estate | Real Estate Operations | -43% | $578.69M | -37.1x | 18.7 | $2.64 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Picocela ADR | NASDAQ | Technology | Communications & Networking | -45.4% | $50.07M | -0.5x | -0.26 | $7.57 | -10.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Zerostack | NASDAQ | Technology | Software & IT Services | -77.8% | $82.38M | -0.2x | -0.03 | $4.71 | -20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| ProCap Financial | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | -78.9% | $194.73M | $2.15 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |